Six North Carolina bioscience companies are among 15 companies from the Southeast selected as finalists for awards to be given at the 20th annual SEBIO Investor and Partnering Forum in Atlanta next month.
Read More
This episode’s deep dive looks at the before, during and the aftermath of Hurricane Florence and how technology can help us get through natural disasters and cut through the clutter.
Read More
Precision BioSciences, a Durham-based genome editing company, has formed a strategic collaboration potentially worth more than $445 million with Gilead Sciences, to develop new therapies aimed at curing hepatitis B infections.
Read More
Durham-based genome editing company Precision BioSciences has raised $110 million to further the development of its proprietary ARCUS genome editing platform.
Read More
Precision BioSciences Inc. has raised more than $88 million in a private equity offering, according to a securities filing.
Read MorePrecision BioSciences subsidiary will bring its genome-editing tech to food and ag industries.
Read More
Five “alumni” companies of the Council for Entrepreneurial Development reported major progress at the CED’s Life Sciences Conference.
Read More
